As a child I was unfortunate to see my grandmother suffer with Alzheimer's, and the strain it can put on loved ones.  The CMS proposal for Medicare to cover drugs that target the treatment of Alzheimer's in Clinical Trials will hopefully further improve innovation in this area.

However, it is vital that it doesn't have a major negative impact on those already suffering with Alzheimer's having affordable access to medication already approved by the FDA.